Kan, S.-H., Harb, J. F., Li, S., Dalton, N. D., Padilla, A., Christensen, C., … Wang, R. Y. (2024). Improvement of hypertrophic cardiomyopathy in knock-in murine model with neonatal gene therapy. In Molecular Genetics and Metabolism (Vol. 141, pp. 107908–107908). Elsevier BV. https://doi.org/10.1016/j.ymgme.2023.107908

Kan, Shih-hsin, Jerry F. Harb, Songtao Li, Nancy D. Dalton, Alejandra Padilla, Chloe Christensen, Allisandra Rha, et al. “Improvement of hypertrophic cardiomyopathy in knock-in murine model with neonatal gene therapy.” In Molecular Genetics and Metabolism, 141:107908–107908. Elsevier BV, 2024. https://doi.org/10.1016/j.ymgme.2023.107908.

Kan S-H, Harb JF, Li S, Dalton ND, Padilla A, Christensen C, et al. Improvement of hypertrophic cardiomyopathy in knock-in murine model with neonatal gene therapy. In: Molecular Genetics and Metabolism. Elsevier BV; 2024. p. 107908–107908.

Kan, Shih-hsin, et al. “Improvement of hypertrophic cardiomyopathy in knock-in murine model with neonatal gene therapy.” Molecular Genetics and Metabolism, vol. 141, no. 2, Elsevier BV, 2024, pp. 107908–107908. Crossref, doi:10.1016/j.ymgme.2023.107908.

Kan S-H, Harb JF, Li S, Dalton ND, Padilla A, Christensen C, Rha A, Andrade-Heckman P, Chan Y, Torres E, Koeberl DD, Wang RY. Improvement of hypertrophic cardiomyopathy in knock-in murine model with neonatal gene therapy. Molecular Genetics and Metabolism. Elsevier BV; 2024. p. 107908–107908.